Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958-2004

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 993-1000

  Oh, Jin Kyoung ^a   Alemany, Laia ^b,c   Suh, Jung Il ^d   Rha, Seo Hee ^e   Muñoz, Nubia ^b   Bosch, F Xavier ^b   Quint, Wim ^f   Lloveras, Belen ^b,g   Klaustermeier, Jo Ellen ^b,c   de Sanjosé, Silvia ^b,c   Shin, Hai Rim ^a,h  

^a National Cancer Center   (South Korea)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d National Medical Center   (South Korea)

^e Dong A University   (South Korea)

^f DDL Diagnostic Laboratory   (Netherlands)

^g HOSPITAL DEL MAR   (Spain)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cervical cancer; Human Papillomavirus; Korea; Trends

Indexed keywords

EID: 78650702286     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ahn SH, Jean KS, Park SJ, et al (1999). Human papillomavirus detection and E6 oncoprotein expression in uterine cervical cancer. Korean J Gynecol Oncol, 42, 2657-65.
2. An HJ, Cho NH, Lee SY, et al (2003). Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer, 97, 1672-80.
3. An HJ, Kim KR, Kim IS, et al (2005). Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: A population-based study. Mod Pathol, 18, 528-34.
4. Bae JH, Lee SJ, Kim CJ, et al (2008). Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol, 18, 788-94.
5. Bosch FX, Manos MM, Munoz N, et al (1995). Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst, 87, 796-802.
6. Cho NH, An HJ, Jeong JK, et al (2003). Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol, 188, 56-62.
7. Clifford GM, Smith JS, Plummer M, et al (2003). Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer, 88, 63-73.
8. Hong SM, Kim IS, Kang JS (1997). The study of low-risk and high-risk human papillomaviruses infection in cervical carcinomas and cervical instaepithelial lesions with hybrid capture system. Korean J Gynecol Oncol, 40, 815-29.
9. Hwang T (1999). Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci, 14, 593-9.
10. Hwang TS, Jeong JK, Park M, et al (2003). Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol, 90, 51-6.
11. Jo H, Jeon YT, Hwang SY, et al (2007). Increasing trend in the incidence of cervical cancer among the elderly in Korea: A population-based study from 1993 to 2002. Acta Oncol, 46, 852-8.
12. Kang SB, Park CS, Jeon HW, et al (1995). Clinical significance of human papillomavirus infection and epidermal growth factor receptor in cervical carcinoma. Korean J Gynecol Oncol Colposc, 6, 140-56.
13. Kim HJ, Song ES. Hwang TS (2001). Higher incidence of p53 mutation in cervical carcinomas with intermediate-risk HPV infection. Eur J Obstet Gynecol Reprod Biol, 98, 213-8.
14. Kim KH, Kim YS (1995). Role of human papillomavirus and p53 tumor suppressor gene in cervical carcinogenesis. Yonsei Med J, 36, 412-25.
15. Kim MK, Kim HB, Lee SK, et al (2002). Human papillomavirus infection and expression of cyclin D1 in the uterine cervical neoplasia. Korean J Gynecol Oncol Colposc, 13, 28-37.
16. Kim SC, Suh SP, Kee SJ, et al (1997). Detection of human papillomavirus in uterine cervical cancer tissues by polymerase chain reaction, in situ hybridization and polymerase chain reaction in situ techniques. Korean J Clin Pathol, 17, 287-95.
17. Kim SN, Park TK (1994). Prognostic significance of human papillomavirus types 16 and 18 in invasive cervical cancer. Korean J Gynecol Oncol Colposc, 5, 1-8.
18. Kim YB, Jeon YT, Seo SS, et al (2003). Prevalence and genotyping of HPV in cervical cancer of Korean women. Korean J Gynecol Oncol, 46, 789-94.
19. Konno R, Shin HR, Kim YT, et al (2008). Human papillomavirus infection and cervical cancer prevention in Japan and Korea. Vaccine, 26, M30-42.
20. Kwon KI, Kim SP, Suh SI, et al (2001). Alterations of p16INK4A and p18INK4C, human papillomavirus infections and expression of the cell cycle associated proteins in cervical carcinomas. Korean J Gynecol Oncol, 44, 683-91.
21. Lee GY, Kim SM, Rim SY., et al (2005). Human papillomavirus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions. Int J Gynecol Cancer, 15, 81-7.
22. Lee HS, Kim KM, Kim SM., et al (2007). Human papillomavirus genotyping using HPV DNA chip analysis in Korean women. Int J Gynecol Cancer, 17, 497-501.
23. Lee JH, Lee KH, Lee IH, et al (2006). Genotyping of human papillomavirus detected with the HPV DNA chip in cervical cancer. Korean J Gynecol Oncol, 49, 858-65.
24. Lee SA, Kang D, Seo SS, et al (2003). Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett, 198, 187-92.
25. Lin ZH, Shen XH, Jin Z, et al (2005). Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women. Pathol Int, 55, 491-6.
26. Moscicki AB, Schiffman M, Kjaer SandVilla LL (2006). Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine, 24, 42-51.
27. Munoz N, Bosch FX, Castellsague X, et al (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 111, 278-85.
28. Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
29. Na JH, Choi HS (2000). Detection of human papillomavirus DNA and p53, p21 gene expression in CIN3 and uterine cervical cancer. J Korean Cancer Assoc, 32, 100-9.
30. Park CS, Song YS, Koh CW, et al (1996). p53 gene, human papillomavirus(HPV), cervical cancer, polymerase chain reaction(PCR), immunohistochemical staining, single strand conformation polymorphism. J Korean Cancer Assoc, 28, 122-37.
31. Park HK, Kang YM, Park JM, et al (2003). Prevalence and genotyping of HPV in different grades of cervical intraepithelial neoplasia and cervical cancer. Korean J Gynecol Oncol Colposc, 14, 123-32.
32. Park HK, Kim YN, Jeong DH, et al (2005). Human papillomavirus (HPV) in lymphatic fluid of patients with cervical cancer. Korean J Gynecol Oncol, 16, 61-9.
33. Park JS, Chee YH, Namkoong SE, et al (1994). Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction. Gynecol Oncol, 53, 344-51.
34. Park MA, Koh SB (2008). Prevalence and distribution of single and multiple HPV infections in cervical cancer and precancerous lesion from daegu and gyeongbuk province. Korean J Obstet Gynecol, 51, 1128-36.
35. Park TC, Kim CJ, Koh YM, et al (2004). Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol, 23, 119-25.
36. Porras C, Rodriguez AC, Hildesheim A, et al (2009). Human papillomavirus types by age in cervical cancer precursors: Predominance of human papillomavirus 16 in young women. Cancer Epidemiol Biomarkers Prev, 18, 863-5.
37. Shin HR, Park S, Hwang SY, et al (2008). Trends in cervical cancer mortality in Korea 1993-2002: Corrected mortality using national death certification data and national cancer incidence data. Int J Cancer, 122, 393-7.
38. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer, 121, 621-32.
39. Sohn HD, Cho YL, Chun SS, et al (1994). Detection rate and prognostic significance of human papillomavirus type 16 and type 18 using PCR method in uterine cervical cancer. Korean J Gynecol Oncol Colposc, 5, 19-28.
40. Suh KS, Cho SJ, Na SY, et al (2004). Human papillomavirus type 16, 18, and 33 infection in adenocarcinoma of the uterine cervix: analysis of the p53 gene mutation and the clincopathologic correlation. Korean J Pathol, 38, 295-300.
41. Wheeler CM, Hunt WC, Joste NE, et al (2009). Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst, 101, 475-87.
42. Won YJ, Sung J, Jung KW, et al (2009). Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat, 41, 122-31.
43. Wui JH, Seong HJ, Lee TS, et al (2006). The distribution of HPV subtype and multiple HPV infection in cervical cancer and precancerous lesion. Korean J Gynecol Oncol, 17, 39-46.
44. zur Hausen H (1996). Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta, 1288, F55-78.